Journalism in the Public Interest

Health Care

Discussion: Acetaminophen Risks, Safety Measures

During the last decade, more than 1,500 Americans have died from accidentally taking too much of an over-the-counter drug renowned for its safety: acetaminophen. Tens of thousands more have been harmed from liver damage associated with the drug.

Meanwhile, federal regulators have known about studies showing the risks associated with acetaminophen for decades. So has McNeil Consumer Healthcare, the Johnson & Johnson unit that built Tylenol into a billion-dollar brand. So how has acetaminophen become America’s most popular pain reliever, despite these risks?

Join ProPublica for a discussion of our investigation into how federal regulators delayed or failed to adopt measures designed to reduce the rising number of deaths and injuries from acetaminophen, and how McNeil, while it undeniably took steps to protect consumers, also fought repeatedly against safety warnings, dosage restrictions and other protective measures.

WHEN: Thursday, Sept. 26, 1 p.m. ET

WHO: ProPublica reporter T. Christian Miller (@txtianmiller) liver disease specialist Dr. William Lee and pharmaceutical marketing expert PeterMax Miller


blog comments powered by Disqus

Projects You Can Help With


Have You Had Difficulty Paying For or Accessing Prescription Drugs? We Want to Hear From You.

Share Your Story


Is Your Member of Congress Telling It Straight On The ACA? Help Us Fact-Check Them.

Letters submitted


About $765 Billion Is Wasted Each Year on Health Care. Can You Help Us Find It?

Tips Submitted


Do You Know Someone Who Died or Nearly Died in Childbirth? Help Us Investigate Maternal Health

Stories Submitted

More on This Investigation

Johnson & Johnson Emerges Victorious in Lawsuit on Tylenol’s Risks

Hundreds of cases are pending that involve claims that Tylenol has caused liver damage and deaths. The pain reliever’s maker won a jury verdict in the first.

New Trial Records: Doctors Recommended Tylenol — But Only at Lower Doses

Internal company documents that have emerged in a New Jersey trial make clear that marketing for Tylenol did not convey doctors’ concerns about its risks.

New Court Docs: Maker of Tylenol Had a Plan to Block Tougher Regulation

Filings from a lawsuit, scheduled to go to trial today in Atlantic City, describe a previously unreported lobbying campaign by McNeil Consumer Healthcare to protect its iconic painkiller.

How Much Acetaminophen a Day is Safe? Canada May Decide It’s Less

After an investigation by the Toronto Star, Canada’s top health agency considers whether to lower the maximum recommended daily dose of the active ingredient in Tylenol and other painkillers.

FDA Opens Review of Rules for Over-the-Counter Drugs, Including Acetaminophen

Federal regulators’ announcement that they will examine the regulation of non-prescription drugs such as acetaminophen, the active ingredient in Tylenol, follows a ProPublica investigation.